AMANDA DEGEE: Open Payments
NPI 1912343724 · WINTER GARDEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,962 in 109 payments from 18 companies in 2025. Trend: 2023 $2,250 · 2024 $1,424 · 2025 $1,962
Food & beverage: $1,962
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 15 | $308 |
| Neurocrine BioSciences, Inc. | 12 | $275 |
| ABBVIE INC. | 20 | $212 |
| Vanda Pharmaceuticals Inc. | 10 | $200 |
| Axsome Therapeutics, Inc. | 9 | $199 |
| Supernus Pharmaceuticals, Inc. | 6 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $138 |
| Lundbeck LLC | 4 | $69 |
| Bausch Health US, LLC | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
Products named: Azstarys, INGREZZA, VRAYLAR, Auvelity, Qelbree, CAPLYTA, HETLIOZ, REXULTI.
Industry payments across FL — which companies pay providers there.
